Myeloid Therapeutics
Latest round
- Series A
Last raised
- May 2023
Total raised
- $108M
Investors
- 6
About Myeloid Therapeutics
Myeloid Therapeutics, Inc.Founded in 2019 and headquartered in Cambridge, US, Myeloid Therapeutics specializes in mRNA-based immunotherapy innovations.00 mn.Myeloid Therapeutics specializes in mRNA-based immunotherapies, focusing on innovative therapies that utilize advanced cell and gene therapy methods. Their core product offerings include a novel in vivo engineering platform designed to target and activate myeloid cells within solid tumors, eliciting a broader anti-tumor adaptive immunity without ex-vivo cell engineering. Additionally, their retrotransposon-mediated gene insertion technology enhances therapeutic potential by delivering larger genetic sequences into the genome.Myeloid Therapeutics generates revenue through collaborations with pharmaceutical companies, research institutions, and healthcare providers. Their revenue model includes licensing agreements, co-development partnerships, and direct sales of proprietary therapies, particularly their mRNA therapies. The company plans to further develop their mRNA-based products and is targeting expansion into new markets, particularly in Europe and Asia, with strategic timelines aimed at product launches within the next two years.
Who invested in Myeloid Therapeutics
6 investors across 2 rounds
See all investors in Myeloid Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Myeloid Therapeutics
Who invested in Myeloid Therapeutics?
Myeloid Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myeloid Therapeutics raised?
Myeloid Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Myeloid Therapeutics last raise money?
Myeloid Therapeutics's most recent round on record is a Series A, in May 2023.
What does Myeloid Therapeutics do?
Myeloid Therapeutics is a biotechnology company.
Where is Myeloid Therapeutics headquartered?
Myeloid Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Myeloid Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Myeloid Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Myeloid Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.